| Item | Amount | Y/Y |
|---|---|---|
| Revenue | $2.12B | +11.9% |
| Gross profit | $1.76B | — |
| Operating income | $0.56B | — |
| Net income | $0.46B | +81.5% |
| Gross margin | 82.8% | Net margin 21.7% |
| Revenue Q/Q | +11.5% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | $0.36B | 17.2% |
| R&D | $0.73B | 34.5% |
| SG&A | $0.45B | 21.0% |
| Tax & other | $0.10B | 4.9% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
ELV ・ EME ・ EMR ・ ETR ・ EOG ・ EQT ・ EFX ・ EQIX ・ EQR ・ ERIE ・ ESS ・ EL
Source: SEC EDGAR · This page shows public filing data only, not investment advice. · Browse all companies